CollPlant Biotechnologies Ltd.
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of CollPlant Biotechnologies Ltd. generated cash of -$2,763,000, which is more than the previous year. Cash used in financing activities reached the amount of $1,108,000 last year. Net change in cash is therefore -$3,190,000.
Cash Flow
| 2014 | -3.32M | -101.95K | 11.55K |
|---|---|---|---|
| 2015 | -3.71M | -355.81K | 2.57M |
| 2016 | -5.03M | -127.90K | 4.80M |
| 2017 | -5.14M | -128.61K | 9.32M |
| 2018 | -1.23M | -956.66K | 2.63M |
| 2019 | -5.70M | -1.46M | 5.41M |
| 2020 | -4.45M | -519K | 4.46M |
| 2021 | 2.50M | -31.55M | 38.76M |
| 2022 | -13.69M | 28.92M | 1.87M |
| 2023 | -2.76M | -1.15M | 1.10M |
CLGN Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 29.86M | 13.37M | 3.52M | 3.97M | 5.66M | 4.73M | 1.09M | 1.38M | 2.83M | 6.10M |
Operating activities | ||||||||||
Net income | -7.01M | -16.92M | 237K | -5.77M | -11.16M | -3.68M | -6.00M | -7.25M | -4.77M | -3.34M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 1.10M | 1.07M | 773K | 660K | 539K | 390.84K | 302.10K | 224.61K | 201.86K | 205.96K |
Stock-based compensation expense | 1.93M | 2.17M | 1.59M | 1.67M | 1.12M | 0 | 1.42M | 928.61K | 1.04M | 52.64K |
| Deferred income tax benefit | 1.93M | 2.17M | 1.59M | 1.67M | 1.12M | 0 | 1.42M | 928.61K | 1.04M | 52.64K |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 159K | 261K | 560K | -751K | 437K | -419.25K | 69.62K | -47.05K | -435.75K | 0 |
Inventories | 749K | -312K | 181K | -374K | -74K | -624.50K | -61.28K | -126.60K | 0 | 0 |
Accounts payable | -153K | 99K | 236K | -35K | 228K | -106.20K | -644.20K | 649.40K | 218.76K | -54.95K |
Cash generated by operating activities | -2.76M | -13.69M | 2.50M | -4.45M | -5.70M | -1.23M | -5.14M | -5.03M | -3.71M | -3.32M |
Investing activities | ||||||||||
Purchases Of Investments | 0 | -20M | -30M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -954K | -1.31M | -1.58M | -519K | -1.49M | -792.04K | -128.61K | -127.90K | -355.81K | -86.28K |
Acquisitions Net | 0 | -30.19M | 33K | 0 | 30K | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | -1.15M | 28.92M | -31.55M | -519K | -1.46M | -956.66K | -128.61K | -127.90K | -355.81K | -101.95K |
Financing activities | ||||||||||
Common Stock Issued | 1.10M | 1.87M | 32.74M | 4.4M | 0 | 2.65M | 8.15M | 4.81M | 2.56M | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | 0 | 0 | -24K | -20K | -78.06K | 0 | -4.93K | 0 | 0 |
Cash used in financing activities | 1.10M | 1.87M | 38.76M | 4.46M | 5.41M | 2.63M | 9.32M | 4.80M | 2.57M | 11.55K |
Net Change In Cash | -3.19M | 16.49M | 9.84M | -445K | -1.69M | 596.88K | 4.03M | -395.15K | -1.47M | -3.26M |
Cash at end of period | 26.67M | 29.86M | 13.37M | 3.52M | 3.97M | 5.32M | 5.12M | 987.10K | 1.36M | 2.84M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source |